Protara Therapeutics TARA Balance Sheet (2013-2026)

NASDAQ TARA
$3.94 -0.03 (-0.76%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Protara Therapeutics Quarterly Balance Sheet

Periods 52 quarters
Latest Jun 2026

Protara Therapeutics reported total assets of $176.09M and total liabilities of $14.78M for the quarter ended Jun 2026, up 12.2% year over year. This balance sheet covers 52 quarters of results from Sep 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
0.82M1.11M1.47M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
40.74M122.04M25.44M33.81M96.83M94.68M21.04M33.98M33.77M39.59M52.23M89.58M51.76M162.80M91.46M31.50M12.55M49.66M14.74M17.08M
Receivables - OtherOther Receivables
Prepaid Assets
1.94M1.88M3.10M2.63M2.35M1.78M8.01M3.90M3.78M3.12M2.69M2.63M3.58M1.86M2.17M2.88M2.97M3.95M4.21M3.66M
Current Assets
95.69M93.11M90.69M101.09M98.67M86.15M94.62M84.27M77.81M68.70M57.91M92.21M85.08M172.16M126.53M125.09M135.64M159.50M140.00M146.15M
Non-Current Assets
Property, Plant & Equipment (Net)
1.73M1.72M1.68M1.64M1.66M1.59M1.52M1.44M1.40M1.30M1.21M1.19M1.11M1.03M0.99M0.91M0.83M0.76M0.67M1.32M
Long-Term Investments
44.65M39.47M30.89M14.35M10.76M17.89M2.89M33.15M23.39M0.96M42.34M41.64M19.36M
Goodwill
29.52M29.52M29.52M29.52M29.52M
Goodwill & Intangibles
29.52M29.52M29.52M29.52M29.52M
Long-Term Deferred Tax
29.35M40.46M54.30M
Other Non-Current Assets
0.95M0.86M0.79M0.81M0.74M0.74M0.74M2.88M2.94M2.94M0.74M0.74M0.74M3.27M0.74M0.74M3.01M2.95M5.98M5.92M
Non-Current Assets
85.00M79.48M70.57M53.79M49.92M27.14M11.79M10.88M10.65M10.25M10.22M9.43M9.01M9.30M42.03M31.84M8.99M49.96M51.93M29.94M
Assets
180.70M172.60M161.26M154.88M148.59M113.29M106.41M95.14M88.47M78.95M68.13M101.65M94.09M181.45M168.56M156.93M144.64M209.47M191.92M176.09M
Liabilities
Current Liabilities
Accounts Payables
0.93M0.95M0.54M0.39M0.46M1.59M4.08M1.85M2.50M2.43M0.97M1.39M2.29M4.43M2.31M5.30M4.50M3.47M4.03M4.66M
Notes Payables
Payables
0.93M0.95M0.54M0.39M0.46M1.59M4.08M1.85M2.50M2.43M0.97M1.39M2.29M4.43M2.31M5.30M4.50M3.47M4.03M4.66M
Accumulated Expenses
1.92M2.49M1.45M2.22M2.35M3.24M1.40M2.13M3.31M2.73M3.53M3.23M5.27M5.41M3.54M3.26M4.18M6.23M3.63M7.37M
Other Accumulated Expenses
0.27M0.25M0.08M0.12M0.18M0.18M0.11M0.10M0.08M0.18M0.27M0.12M0.37M0.14M0.23M0.33M0.33M0.28M0.18M0.53M
Short term Debt
Current Leases
0.84M0.85M0.87M0.89M0.90M0.92M0.93M0.95M0.97M0.98M1.00M1.03M1.08M1.12M1.17M1.20M1.22M1.24M1.26M1.29M
Current Deferred Revenue
Curent Deferred Tax Liability
Total Current Liabilities
3.69M4.30M2.86M3.49M3.71M5.74M6.41M4.93M6.78M6.15M5.50M5.65M8.64M10.96M7.02M9.76M9.91M10.94M8.92M13.32M
Non-Current Liabilities
Preferred Stock Liabilities
Operating Leases
6.60M6.38M6.16M5.93M5.70M5.47M5.23M5.93M5.70M4.48M5.23M4.98M4.74M3.36M4.23M3.95M3.66M2.12M3.06M2.75M
Non-Current Deferred Tax Liability
1.55M0.83M3.42M9.61M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
10.29M10.68M9.02M9.43M9.41M11.21M11.64M9.92M11.51M10.63M9.73M9.60M12.30M14.32M10.07M12.51M12.35M13.06M10.71M14.78M
Shareholder's Equity
Total Debt
Common Equity
170.41M161.91M152.24M145.46M139.18M102.08M94.77M85.22M76.96M68.32M58.41M92.05M81.79M167.13M158.48M144.42M132.29M196.41M181.21M161.31M
Liabilities and Shareholders Equity
180.70M172.60M161.26M154.88M148.59M113.29M106.41M95.14M88.47M78.95M68.13M101.65M94.09M181.45M168.56M156.93M144.64M209.47M191.92M176.09M
Retained Earnings
254.22M256.13M257.93M259.88M261.29M262.72M264.24M265.85M267.27M268.73M269.88M313.02M313.95M412.08M415.25M416.16M417.22M498.69M501.72M503.48M
Preferred Shares
Treasury Shares